CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
BORTDEXADARA Regimen
Denosumab compared with zoledronic acid on PFS in multiple myeloma: exploratory results of an international phase 3 study - ScienceDirect
Treatment of relapsed and refractory multiple myeloma | Haematologica
3630-Multiple myeloma DVd (daratumumab bortezomib dexamethasone) overview | eviQ
DVd - Darzalex + Velcade + dex - Myeloma | ChemoExperts
JPM | Free Full-Text | Targeted Therapies for Multiple Myeloma
Cancers | Free Full-Text | Recent Advances in the Treatment of Patients with Multiple Myeloma
CASTOR study design. RRMM = relapsed or refractory multiple myeloma;... | Download Scientific Diagram
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study - Yimer - 2019 - British Journal of Haematology - Wiley Online Library
JCM | Free Full-Text | Resistance Mechanisms towards CD38−Directed Antibody Therapy in Multiple Myeloma
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study | BMJ Open
Overall survival in a cohort of multiple myeloma patients treated with... | Download Scientific Diagram
Best Practice for the Administration of Daratumumab in Multiple Myeloma: Australian Myeloma Nurse Expert Opinion. - Abstract - Europe PMC
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Treatment of relapsed and refractory multiple myeloma | Haematologica
Multiple myeloma current treatment algorithms | Blood Cancer Journal
Frontiers | Daratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments
DVdSC (weekly cycles 9 onwards) DaratumumabSC-Bortezomib-Dexamethasone Ver1
DVd Weekly Daratumumab-Bortezomib-Dexamethasone Cycles 1 to 8
Frontiers | Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis
Multiple myeloma: 2020 update on diagnosis, risk‐stratification and management - Rajkumar - 2020 - American Journal of Hematology - Wiley Online Library
